Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural Basis of APH(3)-IIIa-Mediated Resistance to N1-Substituted Aminoglycoside Antibiotics

Journal Article · · Antimicrobial Agents and Chemotherapy

Butirosin is unique among the naturally occurring aminoglycosides, having a substituted amino group at position 1 (N1) of the 2-deoxystreptamine ring with an (S)-4-amino-2-hydroxybutyrate (AHB) group. While bacterial resistance to aminoglycosides can be ascribed chiefly to drug inactivation by plasmid-encoded aminoglycoside-modifying enzymes, the presence of an AHB group protects the aminoglycoside from binding to many resistance enzymes, and hence, the antibiotic retains its bactericidal properties. Consequently, several semisynthetic N1-substituted aminoglycosides, such as amikacin, isepamicin, and netilmicin, were developed. Unfortunately, butirosin, amikacin, and isepamicin are not resistant to inactivation by 3'-aminoglycoside O-phosphotransferase type IIIa [APH(3')-IIIa]. We report here the crystal structure of APH(3')-IIIa in complex with an ATP analog, AMPPNP [adenosine 5'-(?,{gamma}-imido)triphosphate], and butirosin A to 2.4-A resolution. The structure shows that butirosin A binds to the enzyme in a manner analogous to other 4,5-disubstituted aminoglycosides, and the flexible antibiotic-binding loop is key to the accommodation of structurally diverse substrates. Based on the crystal structure, we have also constructed a model of APH(3')-IIIa in complex with amikacin, a commonly used semisynthetic N1-substituted 4,6-disubstituted aminoglycoside. Together, these results suggest a strategy to further derivatize the AHB group in order to generate new aminoglycoside derivatives that can elude inactivation by resistance enzymes while maintaining their ability to bind to the ribosomal A site.

Research Organization:
Brookhaven National Laboratory (BNL) National Synchrotron Light Source
Sponsoring Organization:
Doe - Office Of Science
DOE Contract Number:
AC02-98CH10886
OSTI ID:
980508
Report Number(s):
BNL--93426-2010-JA
Journal Information:
Antimicrobial Agents and Chemotherapy, Journal Name: Antimicrobial Agents and Chemotherapy Vol. 53; ISSN 0066-4804; ISSN AMACCQ
Country of Publication:
United States
Language:
English

Similar Records

Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome
Journal Article · Thu Aug 03 00:00:00 EDT 2023 · Nature Communications · OSTI ID:2423521

Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila
Journal Article · Thu Dec 31 23:00:00 EST 2009 · Journal of Biological Chemistry · OSTI ID:1019685

Structural basis for the diversity of the mechanism of nucleotide hydrolysis by the aminoglycoside-2"-phosphotransferases
Journal Article · Thu Nov 28 23:00:00 EST 2019 · Acta Crystallographica. Section D. Structural Biology · OSTI ID:1595141